Revenue: The sum of all revenue fields included for a company's operating activities.
Impact Biomedical Inc. (IBO) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
Revenue |
-- |
$-1.27M |
|
-- |
|
-- |
|
$1.01M |
|
$-1.01M |
|
$-0.27M |
|
$-1.28M |
|
$-1.28M |
|
$-1.28M |
|
$-1.28M |
|
$-1.28M |
|
$-1.28M |
|
$-1.01M |
|
$-0.73M |
|
12.06M |
|
12.06M |
|
$-0.11 |
|
$-0.11 |
|
Balance Sheet Financials | |
$2.18M |
|
$0.02M |
|
$17.87M |
|
$20.05M |
|
$9.97M |
|
-- |
|
$3.27M |
|
$13.24M |
|
$6.75M |
|
$-11.04M |
|
$6.81M |
|
12.09M |
|
Cash Flow Statement Financials | |
$-0.68M |
|
$0.00M |
|
-- |
|
$2.00M |
|
$1.32M |
|
$-0.68M |
|
$0.03M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.22 |
|
-- |
|
-- |
|
-- |
|
1.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.93% |
|
11.57% |
|
-6.37% |
|
-18.77% |
|
$0.56 |
|
$-0.06 |
|
$-0.06 |